Novel Genetic Variant of a Class B G Protein-Coupled Receptor Reveals a Role for Adrenomedullin in Human Fertility

door Hay, Debbie L.
Gepubliceerd in ACS Pharmacol Transl Sci (2018)

Structure–function relationships of the N-terminus of receptor activity-modifying proteins

door Qi, Tao, Hay, Debbie L
Gepubliceerd in 2010

Reply to comment on: A second trigeminal CGRP receptor: function and expression of the AMY1 receptor

door Walker, Christopher S., Hay, Debbie L.
Gepubliceerd in Ann Clin Transl Neurol (2016)

Secretin family (Class B) G protein-coupled receptors – from molecular to clinical perspectives

door Poyner, David R, Hay, Debbie L
Gepubliceerd in 2012

Amylin structure–function relationships and receptor pharmacology: implications for amylin mimetic drug development

door Bower, Rebekah L, Hay, Debbie L
Gepubliceerd in Br J Pharmacol (2016)

RAMPs (Receptor-Activity Modifying Proteins): New Insights and Roles

door Hay, Debbie L., Pioszak, Augen A.
Gepubliceerd in Annu Rev Pharmacol Toxicol (2015)

RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors

door Pioszak, Augen A., Hay, Debbie L.
Gepubliceerd in Adv Pharmacol (2020)

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYI...

door Lee, Sang-Min, Hay, Debbie L., Pioszak, Augen A.
Gepubliceerd in J Biol Chem (2016)

Calcitonin and amylin receptor peptide interaction mechanisms. INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYI...

door Lee, Sang-Min, Hay, Debbie L., Pioszak, Augen A.
Gepubliceerd in J Biol Chem (2016)

Agonist bias and agonist‐dependent antagonism at corticotrophin releasing factor receptors

door Tasma, Zoe, Wills, Peter, Hay, Debbie L., Walker, Christopher S.
Gepubliceerd in Pharmacol Res Perspect (2020)

Antagonism of CGRP Signaling by Rimegepant at Two Receptors

door Pan, Kylie S., Siow, Andrew, Hay, Debbie L., Walker, Christopher S.
Gepubliceerd in Front Pharmacol (2020)

Characterization of the Structure of RAMP1 by Mutagenesis and Molecular Modeling

door Simms, John, Hay, Debbie L., Wheatley, Mark, Poyner, David R.
Gepubliceerd in 2006

The pharmacology of Adrenomedullin 2/Intermedin

door Hong, Yanguo, Hay, Debbie L, Quirion, Remi, Poyner, David R
Gepubliceerd in 2012

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

door Hay, Debbie L, Garelja, Michael L, Poyner, David R, Walker, Christopher S
Gepubliceerd in Br J Pharmacol (2017)

Differential activation of G-proteins by μ-opioid receptor agonists

door Saidak, Zuzana, Blake-Palmer, Katherine, Hay, Debbie L, Northup, John K, Glass, Michelle
Gepubliceerd in 2006

The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling

door Kuwasako, Kenji, Hay, Debbie L, Nagata, Sayaka, Hikosaka, Tomomi, Kitamura, Kazuo, Kato, Johji
Gepubliceerd in 2012

Analysis of Amylin Consensus Sequences Suggests that Human Amylin is Not Optimized to Minimize Amyloid Formation and Provides Clues to Factors that Modulate Amyloidogenicity

door Noh, Daeun, Bower, Rebekah L, Hay, Debbie L, Zhyvoloup, Alexander, Raleigh, Daniel P
Gepubliceerd in ACS Chem Biol (2020)

Structure–activity relationships for α-calcitonin gene-related peptide

door Watkins, Harriet A, Rathbone, Dan L, Barwell, James, Hay, Debbie L, Poyner, David R
Gepubliceerd in 2013

CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured

door Walker, Christopher S, Raddant, Ann C, Woolley, Michael J, Russo, Andrew F, Hay, Debbie L
Gepubliceerd in Cephalalgia (2017)

Probing the Mechanism of Receptor Activity–Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Pept...

door Booe, Jason M., Warner, Margaret L., Roehrkasse, Amanda M., Hay, Debbie L., Pioszak, Augen A.
Gepubliceerd in Mol Pharmacol (2018)